# Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

Study · id `cardio:ct-nct06773364` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06773364](<https://clinicaltrials.gov/study/NCT06773364>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06773364

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2423 participants.

## Technical summary

Registry record NCT06773364. Randomized; single masking; primary purpose treatment. Start 2025-04-30 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2423 participants (planned count; ClinicalTrials.gov record NCT06773364, source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)
- Started: 2025-04-30 (actual) (ClinicalTrials.gov record NCT06773364, source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT06773364, source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)
- Completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT06773364, source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06773364, source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06773364-2025-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
- Acronym: EAST
- Condition: Suspected Stroke
- Intervention (Drug): Levetiracetam
- Intervention (Other): Guide-recommended management
- Intervention (Other): The lying flat (0°) head position
- Intervention (Other): The sitting-up (≥30°) head position
- Lead sponsor: Shanghai East Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Shanghai East Hospital (`cardio:org-shanghai-east-hospital`)

## Provenance

Content hash: 408990dd8eade53ecd0e08c09e291fabaaedc1ed7e449d42962e5f388e75fbec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
